focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,166.00
Bid: 12,132.00
Ask: 12,136.00
Change: -6.00 (-0.05%)
Spread: 4.00 (0.033%)
Open: 12,180.00
High: 12,198.00
Low: 12,076.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

A COVID-19 shot for $150? Online scams surge as slow vaccine rollout frustrates

Tue, 05th Jan 2021 12:00

By Tina Bellon

NEW YORK, Jan 5 (Reuters) - As millions of people await
their turn to get a COVID-19 vaccine that could be months away,
scammers online, in emails and on messaging apps are luring
victims with claims they can deliver shots within days for as
little as $150.

COVID-19 vaccine scams are on the rise, according to
European and U.S. government officials who are warning the
public of fraudsters out for money and personal data.

A Reuters search online, in dark web forums and on messaging
app Telegram found seven different offers for alleged COVID-19
vaccines.

Scams include emails promising entry to supposedly secret
lists for early vaccine access and robocallers impersonating
government agencies. Message boards on the so-called dark web
have added COVID-19 vaccines to more traditional illicit goods
for sale.

The U.S. FBI and Interpol, among others, have warned of
emerging pandemic-related fraud schemes, saying false cures and
vaccines advertised on fake websites could pose cyber threats
and a significant risk to peoples' health, or even lives.

Website domains containing the word vaccine in combination
with COVID-19 or coronavirus more than doubled since October to
roughly 2,500 in November, when the first legitimate vaccines
were nearing regulatory approval, according to cybersecurity
firm Recorded Future, which is tracking COVID-19 fraud online.

"So far a lot of these domains just appear to be
opportunistic registrations, but some are going to be used for
phishing attempts to have people click on (malicious) links,"
said Lindsay Kaye, director of operational outcomes at Recorded
Future.

Kaye said her team, which also scours the dark web, so far
has not come across any legitimate vaccine diverted from
healthcare facilities or national stockpiles.

The scams are preying on concerns about the far
slower-than-promised rollout of vaccines to protect against the
virus that has claimed more than 1.8 million lives worldwide so
far. Most people will likely have to wait well into the spring,
or even summer, to get their shot.

In the United States, only about 4.5 million people had
received their first shot as of Monday, the U.S. Centers for
Disease Control and Prevention reported. That is a fraction of
the 20 million who were supposed to have been vaccinated by the
end of 2020, according to earlier government forecasts.

VACCINES, GUNS AND MONEY

On dark web forum Agartha, fake COVID-19 vaccines were
offered next to cocaine, opioid medication, "super high quality
fake money," hand guns and gift cards. Posts showed stock photos
of vaccines and offered vials for $500 and $1,000, or the
equivalent in Bitcoin.

On another dark web site, a seller claiming to be from the
"Wuhan Institute of Science" offered COVID-19 vaccines in
exchange for a donation, and asked buyers to provide their
medical history.

On Telegram, several channels claimed to offer COVID-19
vaccines, accompanied by stock images. One user offered supposed
Moderna Inc vaccines for $180, and claimed the vaccine
from Pfizer Inc and BioNTech SE could be had
for $150 and AstraZeneca's for $110 per vial.

Asked how the vaccines would be shipped, the account creator
said they were transported in "regulated temperature packs" and
ice packs within a few days, or overnight for an additional
charge.

Actual COVID-19 vaccines, particularly the Pfizer/BioNTech
offering, must be temperature controlled to remain effective,
with drugmakers equipping shipments with temperature trackers to
ensure the cold chain. Vaccine shipments and distribution are
also tightly controlled by officials and will be administered
at no cost.

The United States has so far authorized two COVID-19
vaccines for emergency use - the ones from Pfizer/BioNTech and
Moderna. The European Union to date has authorized the
Pfizer/BioNTech vaccine and is expected to clear the Moderna
vaccine this week.

The UK has already authorized those two and just added the
vaccine developed by Oxford University with AstraZeneca.

Asked about vaccine scams, Pfizer said it had taken
meticulous steps to reduce the risk of counterfeiting and
tracked trends very carefully.

"Patients should never try to secure a vaccine online - no
legitimate vaccine is sold online - and only get vaccinated at
certified vaccination centers or by certified healthcare
providers," a Pfizer spokesman said in a statement.

Moderna referred a request for comment to the U.S.
Department of Health and Human Services (HHS), which did not
respond. AstraZeneca did not respond to a request for comment.

The HHS, FBI and U.S. Department of Justice have urged the
public to report any COVID-19 vaccine scams, including people
asking for out-of-pocket payments for the vaccine and online
vaccine advertisements.

(Reporting by Tina Bellon in New York
Editing by Bill Berkrot)

More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.